Display options
Share it on

Genomics Inform. 2014 Dec;12(4):240-6. doi: 10.5808/GI.2014.12.4.240. Epub 2014 Dec 31.

Identification and Functional Characterization of P159L Mutation in HNF1B in a Family with Maturity-Onset Diabetes of the Young 5 (MODY5).

Genomics & informatics

Eun Ky Kim, Ji Seon Lee, Hae Il Cheong, Sung Soo Chung, Soo Heon Kwak, Kyong Soo Park

Affiliations

  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea. ; Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
  2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea.
  3. Department of Pediatrics, Seoul National University Children's Hospital, Seoul 110-744, Korea. ; Research Coordination Center for Rare Diseases, Seoul National University Hospital, Seoul 110-744, Korea. ; Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 110-744, Korea.
  4. Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
  5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea. ; Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea. ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 110-744, Korea.

PMID: 25705165 PMCID: PMC4330261 DOI: 10.5808/GI.2014.12.4.240

Abstract

Mutation in HNF1B, the hepatocyte nuclear factor-1β (HNF-1β) gene, results in maturity-onset diabetes of the young (MODY) 5, which is characterized by gradual impairment of insulin secretion. However, the functional role of HNF-1β in insulin secretion and glucose metabolism is not fully understood. We identified a family with early-onset diabetes that fulfilled the criteria of MODY. Sanger sequencing revealed that a heterozygous P159L (CCT to CTT in codon 159 in the DNA-binding domain) mutation in HNF1B was segregated according to the affected status. To investigate the functional consequences of this HNF1B mutation, we generated a P159L HNF1B construct. The wild-type and mutant HNF1B constructs were transfected into COS-7 cells in the presence of the promoter sequence of human glucose transporter type 2 (GLUT2). The luciferase reporter assay revealed that P159L HNF1B had decreased transcriptional activity compared to wild-type (p < 0.05). Electrophoretic mobility shift assay showed reduced DNA binding activity of P159L HNF1B. In the MIN6 pancreatic β-cell line, overexpression of the P159L mutant was significantly associated with decreased mRNA levels of GLUT2 compared to wild-type (p < 0.05). However, INS expression was not different between the wild-type and mutant HNF1B constructs. These findings suggests that the impaired insulin secretion in this family with the P159L HNF1B mutation may be related to altered GLUT2 expression in β-cells rather than decreased insulin gene expression. In conclusion, we have identified a Korean family with an HNF1B mutation and characterized its effect on the pathogenesis of diabetes.

Keywords: glucose transporter type 2; hepatocyte nuclear factor-1β; point mutation; type 2 diabetes mellitus

References

  1. Hum Mol Genet. 2006 Aug 1;15(15):2363-75 - PubMed
  2. Diabetologia. 2004 May;47(5):937-42 - PubMed
  3. N Engl J Med. 2001 Sep 27;345(13):971-80 - PubMed
  4. Chin Med J (Engl). 2010 Nov;123(22):3326-33 - PubMed
  5. Am J Physiol. 1996 Apr;270(4 Pt 1):G541-53 - PubMed
  6. Diabetes. 1998 Aug;47(8):1354-5 - PubMed
  7. J Mol Endocrinol. 2001 Aug;27(1):11-29 - PubMed
  8. J Biol Chem. 1999 May 7;274(19):12975-8 - PubMed
  9. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4695-700 - PubMed
  10. Diabetes Metab Syndr Obes. 2012;5:101-8 - PubMed
  11. Hum Mol Genet. 2004 Dec 15;13(24):3139-49 - PubMed
  12. Ann Intern Med. 2004 Apr 6;140(7):510-7 - PubMed
  13. Nephrol Dial Transplant. 2004 Nov;19(11):2703-8 - PubMed
  14. J Am Soc Nephrol. 2007 Mar;18(3):923-33 - PubMed
  15. J Am Soc Nephrol. 2006 Feb;17(2):497-503 - PubMed
  16. Kidney Int. 2000 Mar;57(3):898-907 - PubMed
  17. Diabetologia. 2003 May;46(5):721-7 - PubMed
  18. Mech Dev. 1999 Dec;89(1-2):211-3 - PubMed
  19. Nat Genet. 1997 Dec;17(4):384-5 - PubMed
  20. Diabetologia. 2004 Apr;47(4):597-613 - PubMed
  21. Swiss Med Wkly. 2012 Oct 04;142:w13690 - PubMed
  22. Eur J Biochem. 1994 Feb 1;219(3):713-25 - PubMed
  23. Diabetologia. 2001 Mar;44(3):387-8 - PubMed
  24. Diabetologia. 2002 Jan;45(1):154-5 - PubMed
  25. J Clin Endocrinol Metab. 2004 Mar;89(3):1369-78 - PubMed
  26. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1490-5 - PubMed
  27. J Clin Endocrinol Metab. 2002 Aug;87(8):3859-63 - PubMed
  28. Endocr J. 2003 Oct;50(5):491-9 - PubMed
  29. Genes Dev. 1991 Jun;5(6):1042-56 - PubMed
  30. J Clin Endocrinol Metab. 2009 Jul;94(7):2658-64 - PubMed
  31. Diabetes Care. 2004 May;27(5):1102-7 - PubMed
  32. Diabetologia. 2002 Jan;45(1):153-4 - PubMed
  33. Nat Genet. 1997 Nov;17(3):327-30 - PubMed
  34. Hum Mol Genet. 1999 Oct;8(11):2001-8 - PubMed
  35. Nat Genet. 1997 Nov;17(3):249-50 - PubMed
  36. Mech Dev. 2003 Jan;120(1):65-80 - PubMed

Publication Types